We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Bronchial Rheoplasty System Targets Chronic Bronchitis

By HospiMedica International staff writers
Posted on 01 Mar 2021
Print article
Image: The RheOx bronchial rheoplasty system (Photo courtesy of Gala Therapeutics)
Image: The RheOx bronchial rheoplasty system (Photo courtesy of Gala Therapeutics)
A novel electrosurgical system delivers non-thermal pulsed energy to the airways to improve the cough and mucus symptoms of chronic bronchitis.

The Gala Therapeutics (Menlo Park, CA, USA) RheOxh system is comprised of an ablation catheter that targets the cells responsible for mucus hypersecretion in the airways, and a complementary minimally-invasive bronchoscopic procedure to deliver the catheter to the lungs. Once in place, the RheOx catheter delivers short bursts of high frequency, short duration electrical energy to the inner walls of the bronchi, causing the mucus-producing cells to break open and die.

Within days, the abnormal cells in the airway epithelium and sub-mucosal tissue layers are replaced by new cells, which produce less mucus and improve the cough response and mucus symptoms of chronic bronchitis. The treatment involves two sessions delivered under general anesthesia. The right lung is treated during the first treatment session and the left lung is treated at the second treatment session, approximately one month later.

“Patients with Chronic Bronchitis suffer daily with mucus hypersecretion and cough. We developed the Bronchial Rheoplasty procedure to directly treat the abnormal airway cells responsible for chronic bronchitis, which are not impacted by inhaled medications,” said Jonathan Waldstreicher, MD, CEO of Gala Therapeutics. “This is a significant milestone towards bringing a breakthrough therapy to millions of chronic bronchitis patients in the United States.”

“Chronic bronchitis is a debilitating disease which results in symptoms that impact quality of life which commonly persist following guideline based medical treatment,” said Professor Frank Sciurba, MD, of the University of Pittsburgh (PA, USA). “Prior feasibility study results suggest that bronchial rheoplasty using RheOx is well tolerated, reduces symptoms, and may significantly improve quality of life for patients.”

Chronic bronchitis is the most common subtype of chronic obstructive pulmonary disease (COPD), and is associated with increased cough, excessive phlegm and shortness of breath for more than three months of each year. It mainly affects smokers and former smokers, but secondhand smoke, vaping, exposure to airborne chemicals, pollution, and other irritants can also contribute to the disease. Despite treatment with inhalers, many patients have persistent symptoms.

Related Links:
Gala Therapeutics

New
Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Flexible Examination Light
ri-magic LED
New
Vital Signs Monitor
Aurus 20 A
New
Blood Warmer
SAHARA-III 230 V

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Surgical Techniques

view channel
Image: The neuro-chip with soft implantable electrodes could manage brain disorders (Photo courtesy of EPFL)

Implantable Neuro-Chip Uses Machine Learning Algorithm to Detect and Treat Neurological Disorders

Using a combination of low-power chip design, machine learning algorithms, and soft implantable electrodes, researchers have produced a neural interface that can identify and suppress symptoms of different... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.